Back to TCRX
GSA CAPITAL PARTNERS LLP → TCRX
GSA CAPITAL PARTNERS LLP TCRX Position History
TScan Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$161K
Q3 2026
Peak value
$537K
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $226K |
| Q1 2026 | $383K |
| Q2 2026 | $537K |
| Q3 2026 | $161K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $161K | 510.7K | — | — |
| Q2 2026 | $537K | 548.1K | — | — |
| Q1 2026 | $383K | 379.0K | — | — |
| Q4 2025 | $226K | 226.2K | — | — |
Other funds holding TCRX
$630M
$630M
$617.5M
$198.1M
$10.9M